Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=825493

Health and economic benefits of increased β-blocker use following myocardial infarction

Author
PHILLIPS, Kathryn A1 ; SHLIPAK, Michael G2 3 ; COXSON, Pam3 ; HEIDENREICH, Paul A4 ; HUNINK, M. C5 6 ; GOLDMAN, Paula A5 ; WILLIAMS, Lawrence W5 ; WEINSTEIN, Milton C; GOLDMAN, Lee3
[1] Department of Clinical Pharmacy, Institute for Health Policy Studies, and Center of Excellence on Health Care Markets and Managed Care and Department of Medicine, University of California, San Francisco, United States
[2] San Francisco Veterans Affairs Medical Center, Palo Alto, Calif, United States
[3] Department of Medicine, University of Californi, San Francisco, United States
[4] Palo Alto VA Health Care System and Department of Medicine, Stanford University, Palo Alto, Calif, United States
[5] Department of Health Policy and Management, Harvard School of Public Health, Boston, Mass, Netherlands
[6] Erasmus University Medical Center, Rotterdam, Netherlands
Source

JAMA, the journal of the American Medical Association. 2000, Vol 284, Num 21, pp 2748-2754 ; ref : 51 ref

ISSN
0098-7484
Scientific domain
General medicine general surgery
Publisher
American Medical Association, Chicago, IL
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Antagoniste Aspect économique Bloquant β-adrénergique Chimiothérapie Economie santé Efficacité traitement Homme Infarctus Myocarde Récepteur β-adrénergique Santé publique Traitement Appareil circulatoire pathologie Cardiopathie coronaire Myocarde pathologie
Keyword (en)
Antagonist Economic aspect Beta blocking agent Chemotherapy Health economy Treatment efficiency Human Infarct Myocardium β-Adrenergic receptor Public health Treatment Cardiovascular disease Coronary heart disease Myocardial disease
Keyword (es)
Antagonista Aspecto económico Bloqueador β-adrenérgico Quimioterapia Economía salud Eficacia tratamiento Hombre Infarto Miocardio Receptor β-adrenérgico Salud pública Tratamiento Aparato circulatorio patología Cardiopatía coronaria Miocardio patología
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F02 Antiarythmic agents

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
825493

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web